Showing 351-360 of 791 results for "".
Systemic Corticosteroids, Chronic Inflammatory Skin Disease, and COVID-19: What Do We Know?
https://practicaldermatology.com/topics/infections-infectious-disease/systemic-corticosteroids-chronic-inflammatory-skin-disease-and-covid-19-what-do-we-know/23615/An assessment of the risk of COVID-19 infection imposed by systemic corticosteroid use in the setting of chronic inflammatory skin disease.Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.Basosquamous Carcinoma: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basosquamous-carcinoma-a-case-series/23815/Basaloid carcinoma, a form of poorly differentiated squamous cell carcinoma, shares histologic similarities with basal cell carcinoma.Treating Psoriasis with FDA-Approved Medications in 2020
https://practicaldermatology.com/topics/psoriasis/treating-psoriasis-with-fda-approved-medications-in-2020/23212/A reference for all of the FDA-approved medications separated into topical treatments and systemic treatments.Electrical Impedance Spectroscopy: Augmented Intelligence Technology for the Early Detection of Melanona
https://practicaldermatology.com/topics/skin-cancer-photoprotection/electrical-impedance-spectroscopy-augmented-intelligence-technology-for-the-early-detection-of-melanona/23262/The Osteopathic Dermatologist: Dr. Peter Ilowite Shares His Craft
https://practicaldermatology.com/topics/practice-management/the-osteopathic-dermatologist-dr-peter-ilowite-shares-his-craft/21116/First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.Preparation: The Cornerstone for Effective, Efficient EHR Use
https://practicaldermatology.com/topics/practice-management/preparation-the-cornerstone-for-effective-efficient-ehr-use/21269/Basal Cell Carcinoma in Skin of Color: Diagnosis and Treatment Considerations
https://practicaldermatology.com/topics/general-topics/basal-cell-carcinoma-in-skin-of-color-diagnosis-and-treatment-considerations/21177/BCC may be less common in more darkly pigmented skin, but it occurs, and diagnosis may be delayed. Appropriate treatment is crucial.Which Probiotic for Which Disease? Part 1
https://practicaldermatology.com/topics/atopic-dermatitis/which-probiotic-for-which-disease-part-1/23550/Enhanced interest in probiotics means clinicians need to pick the best strain for common dermatologic conditions.